Biol Reprod Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aplin, J. D.
Right arrow Articles by Vicovac, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aplin, J. D.
Right arrow Articles by Vicovac, L.
Agricola
Right arrow Articles by Aplin, J. D.
Right arrow Articles by Vicovac, L.
Biology of Reproduction 60, 828-838 (1999)
©Copyright 1999 Society for the Study of Reproduction, Inc.

Development of Cytotrophoblast Columns from Explanted First-Trimester Human Placental Villi: Role of Fibronectin and Integrin {alpha}5ß11

John D. Aplin2,a, Teresa Haigha, Carolyn J.P. Jonesb, Heather J. Churcha, and Ljiljana Vicovac3,a

a Departments of Obstetrics and Gynaecology, b Pathological Sciences, and School of Biological Sciences, University of Manchester, Manchester M13 0JH, United Kingdom


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Human first-trimester floating mesenchymal villi explanted onto gels of collagen I or Matrigel were observed to undergo de novo development of anchoring sites. These consisted of cytotrophoblast columns that formed by proliferation of stem villous cytotrophoblast cells, as revealed by whole-mount and thin-section microscopy and incorporation of bromodeoxyuridine into DNA. Column formation occurred exclusively at the distal tips of the villi. No column formation was observed in tissue explanted onto agarose. On Matrigel, the developing columns penetrated downwards into the matrix, whereas on collagen I, cytotrophoblast sheets spread across the surface of the gel and merged to form a shell. The developing columnar cytotrophoblast up-regulated integrins {alpha}1ß1 and {alpha}5ß1 and produced an extracellular matrix containing oncofetal fibronectin, as in vivo. Function-blocking antibodies were used to investigate the role of the integrin-fibronectin interaction in anchoring villus development on collagen I. Antibodies to fibronectin and the integrin subunits {alpha}5 and ß1, added at 24 h, all changed the pattern of cytotrophoblast outgrowth. Anti-fibronectin caused cell rounding within the cytotrophoblast sheet and increased the population of single cells at its periphery. Anti-integrin {alpha}5 caused rounding and redistribution of cells within the outgrowth. In the presence of anti-integrin ß1, cell-collagen interactions within the sheet were destabilized, often leading to the appearance of an annulus of aggregated cells at the periphery. These results show that 1) mesenchymal villi retain the potential to form anchoring sites until at least the end of the first trimester, 2) adhesion to a permissive extracellular matrix stimulates cytotrophoblast proliferation and differentiation along the extravillous lineage, 3) integrin {alpha}5ß1-fibronectin interactions contribute significantly to anchorage of the placenta to uterine extracellular matrix. We suggest that as the developing placenta ramifies, new sites of anchorage form whenever peripheral villi contact decidua. This process is predicted to contribute to the stability of the placental-decidual interface.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Anchoring villi are peripheral trophoblastic specializations that attach the placenta to the uterine wall [1]. In addition, they supply the migratory trophoblast population that colonizes the maternal interstitium and arteries during the first 18 wk of pregnancy [2, 3]. Establishment of anchoring villi and subsequent invasion of maternal uterine stroma and blood vessels play a critical role in pregnancy success; incomplete vascular invasion is associated with common pathological conditions of pregnancy including pre-eclampsia and growth retardation [4].

Most information on the cytotrophoblast phenotype has been gained from histological studies of pregnancy hysterectomies [2], while the invasive potential of normal cytotrophoblast has been confirmed using primary cultures [5]. However, currently available cell isolation protocols produce a mixture of different cytotrophoblast populations [6,7] that suffer from alterations in phenotype and the possible loss of critical properties in vitro [8]. Explant culture offers the potential to maintain the basic architecture of placental tissue at anchorage sites. We and others have previously shown that explants of placental villi from the first trimester of pregnancy can progress into the extravillous lineage in vitro [911]. Contact coculture of first-trimester mesenchymal villi with decidual tissue has been shown to support anchoring villus formation and cytotrophoblast migration in vitro [1012], but the mechanism by which maternal tissue influences these morphogenetic events is currently uncertain. There are likely to be paracrine effects mediated by diffusible substances [12].

There is also the possibility that physical anchorage of trophoblast to a permissive extracellular matrix (ECM) could trigger progression into the extravillous lineage. Signals from the ECM, transduced by integrins, have been shown to mediate alterations in cell shape, adhesion, and migration, and also to play a role in the regulation of proliferation and differentiative transitions in other cell types [13]. Fibronectin (FN) is abundant at sites of anchoring villus formation in vivo; since cytotrophoblast produces the oncofetal isoform (oFN [14]), which is distinguishable by virtue of a unique glycopeptide epitope [15], it is clear that both maternal and trophoblast-derived FN are present in the ECM encountered by trophoblast in the extravillous pathway [16]. Cytotrophoblast undergoes a change of cell surface phenotype during its differentiation into the extravillous lineage [1721], with loss of integrin {alpha}6ß4 and rapid up-regulation of other integrins including the FN receptor {alpha}5ß1. In the present study, we have undertaken to dissect the differentiative pathway of cytotrophoblast, seeking to distinguish steps that may occur as a result of interaction with the ECM from those that require other signals. On the basis of observations of the cell surface and ECM phenotype of extravillous cytotrophoblast, we focus on the role of integrin-FN interactions in these events.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Reagents

Collagen type I (rat tail tendon), Matrigel, and agarose were obtained from Stratech Scientific Ltd. (Luton, UK). Dulbecco's Modified Eagle's Medium (DMEM) and Ham's F-12 were from Gibco (Life Technologies, Paisley, UK) or Sigma (Poole, UK). Fetal calf serum (FCS) was from Gibco; bromodeoxyuridine (BrdU) was from BCL (Lewes, UK).

Antibodies

Details of the primary antibodies used in this study are given in Table 1. Rabbit polyclonal anti-FN was raised to plasma FN and was previously shown to inhibit cell adhesion to FN monolayers [22]. Monoclonal antibody (mAb) X18A4 is specific to the oncofetal isoform of FN (oFN [23]). Monoclonal Ab 13 to integrin ß1 recognizes all heterodimeric ({alpha}xß1) complexes involving this subunit and is a potent inhibitor of integrin ß1-mediated cell adhesion [22, 24, 25]. Monoclonal Ab B1E5 to integrin {alpha}5 is also function-inhibiting [22]. Several antibodies to members of the integrin {alpha}v family are listed in Table 1 and were used for localization studies. For function-blocking experiments, mouse mAb LM609 to integrin {alpha}vß3 was used. Monoclonal Ab C8F12 to {alpha}v was obtained from C.H. Streuli (University of Manchester). Anti-proliferating cell nuclear antigen (PCNA) antibody was from Dako (High Wycombe, UK).


View this table:
[in this window]
[in a new window]
 
TABLE 1. Antibodies used in the study.

Tissue Collection

Normal placenta was obtained at elective termination of pregnancy by evacuation in the first trimester. The tissue ranged from 8 to 12 wk gestation. It was collected into PBS with antibiotics for transport to the laboratory. For culture experiments, small pieces of tissue (~2–3 mm) containing several floating mesenchymal villi were dissected from the periphery. Specimens of this "zero-time" tissue were fixed and sectioned for comparative histology.

Culture On Gels

Gels were prepared by placing a drop (~85 µl) of the appropriate substrate in 12-well culture dishes. One percent agarose was prepared by melting a stock of 2% agarose in double-strength salt solution and mixing with double-strength DMEM (prediluted from 10-strength stock). Nine parts of concentrated collagen I (4.75–5.25 mg/ml) were mixed with 1 part of 10-strength medium, and the pH was adjusted to neutral. Matrigel was aliquoted at 4°C and warmed to 37°C to gel. Gels were produced at least 24 h before use and incubated in medium at 37°C to allow full contracture.

After the villous tissue was dissected, medium was drained from the gel droplets, and the tissue was arranged on top with villi in a radial orientation and gently covered with ~20 µl of culture medium. The cultures were incubated for 2 h to allow tissue to adhere to the gel, and then carefully flooded with 1 ml of culture medium (1:1 DMEM:F12, 10% FCS). Culture was continued in an atmosphere of 5% CO2 in air at 37°C for various time periods up to 7 days. Cultures were inspected and media changed daily. For identification of newly synthesized DNA, BrdU was added to the cultures at 100 µM for the periods specified in Results. In order to measure the effects on the explants of antibodies to integrins or FN, an initial period of 24-h anchorage to the gel was allowed. After this time, the culture medium was changed, and antibody was introduced at the concentration given in Table 1. Media were subsequently changed every 24 h with the introduction of fresh antibody. Antibody concentrations were based on maximal inhibition in cell adhesion assays carried out using BeWo cells [22]. Explant morphology naturally varies, but the antibody inhibition data are representative of explants of at least 6 placentas cultured in triplicate.

Tissue Processing and Microscopy

Tissue was fixed and processed for semithin, light, and transmission electron microscopy examination, and was also snap-frozen, cryosectioned, and processed for immunohistochemistry as previously described [11, 18]. For visualization of incorporated BrdU, sections were mounted on poly-L-lysine-coated slides and pretreated with 2 M HCl (1 h, room temperature), then neutralized by immersion in 0.1 M borate pH 8.5, washed in PBS, and incubated overnight in mouse anti-BrdU antibody (1/20; BCL) as previously described [18]. PCNA staining used antibody at 1/100 and the same standard immunoperoxidase method. Whole mounts and semithin sections were imaged using a Kontron KS400 system (Kontron Elektronik GmbH, Eching, Germany).


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Morphology of Explant Cultures

Collagen I supported efficient and rapid (within 3 h) attachment of the explanted tissue (Table 2). Radial outgrowth from one to several cells deep was apparent in the plane of the gel surface (Figs. 1, 2, 3A, 3C; see also Fig. 9A), and all outgrowing cells were cytokeratin-positive (Fig. 3, C and D). Elongated bipolar cells were prominent at the edge of the outgrowths (Figs. 1D, 3A, 4A; see also 8B and 9A). Outgrowth occurred specifically from the tips of mesenchymal villi (Fig. 1) and was visible as early as 12–18 h of culture, although in some cases activity became apparent only on the second day in vitro. Not all tips produced outgrowths even when they appeared to be stably attached to the gel surface. However, multiple foci of outgrowth were usually observed from adjacent villi, and with increasing time these fused to form a continuous sheet of cytotrophoblast resembling a shell (Figs. 1B and 3A). Most of the outgrowth activity occurred between Days 1 and 4 (Fig. 2). The size of the outgrowth varied widely between cultures (Fig. 2). This variation was apparent in different cultures produced from the same or different placentas, and appeared to depend mainly on the size of the sites of origin where villous tips contacted the gel surface. This behavior could be observed in tissue obtained from all gestational ages under study (8–12 wk), and no alteration was observed in this range. Within the sheet, cells were multilayered and had prominent cytoplasmic glycogen masses, intermediate filament bundles, and desmosomal junctions (Fig. 4). Some cells penetrated a short distance into the collagen gel, but extensive infiltration or erosion of the collagen gel was not apparent (Figs. 3C, 4A, 4B; see also 9A). A population of detached single cells could be observed at the periphery of the cytotrophoblastic shell (Fig. 3A; see also 8B). These cells were mainly rounded and did not migrate further.


View this table:
[in this window]
[in a new window]
 
TABLE 2. Characteristics of different gel matrices with respect to attachment of villi and outgrowth of trophoblast at 48 h.a



View larger version (187K):
[in this window]
[in a new window]
 
FIG. 1. Explant (2–3 mm) of first-trimester mesenchymal villous tissue on collagen I after A) 1, B) 2, and C) 3 days. The dark areas are tissue, and sheets of outgrowing cytotrophoblast can readily be observed. Arrows mark the edges of the outgrowth. Note that after 1 day, two sites of origin are present. After 2 days, several sites in the tissue are contributing to the trophoblast outgrowth, which has already merged into a shell-like structure. D) At higher magnification, elongated cells (arrows) are apparent at the periphery (36 h). Scale bars: B) 300 µm; D) 38 µm.



View larger version (18K):
[in this window]
[in a new window]
 
FIG. 2. Time course of trophoblast outgrowth. Changes in area were followed in explant cultures as shown in Figure 1 either at 1, 2, and 3 days (A) or 1, 4, and 5 days (B). All the experiments showed significant outgrowths, readily visible by low-power microscopy of whole mounts, but note that different sites varied greatly in area, depending mainly on the size and number of the sites of origin. In a minority of experiments, significant outgrowth was apparent at 24 h (half-filled circles in A; half-filled squares in B), but in general, the majority of activity occurred between Days 1 and 3. As illustrated in B, typically only about a 5% increase of trophoblast area occurred between Days 4 and 5, after which little further spreading of the cell sheet was evident. Area units are arbitrary.



View larger version (125K):
[in this window]
[in a new window]
 
FIG. 3. Whole mounts (A, B) and cytokeratin immunostained sections (C, D) of villi on three-dimensional matrices of collagen I (A, C) or Matrigel (B, D) after 48 h of culture. On collagen gel (A), extensive outgrowth has occurred along the gel surface from several centers and fused to form a shell-like structure (bright area). This comprises a sheet of cytokeratin-positive cytotrophoblast (C). In Matrigel (B), only small projections can be seen in whole mount (arrow), and cytotrophoblast outgrowth occurs mainly into the matrix (D). Scale bar: A) 5.1 mm; B) 1.7 mm; C) 170 µm; D) 250 µm.



View larger version (76K):
[in this window]
[in a new window]
 
FIG. 9. Semithin sections of explant cultures after treatment with integrin function-blocking antibodies. The total time in culture was 5 days, with antibody exposure during the last 4 days. Each field contains villous tissue at left with a cytotrophoblast outgrowth that moved from left to right across the surface of the collagen gel, which is in the lower part of each frame. A) Control experiment, B) anti-integrin {alpha}5ß1, C) anti-integrin {alpha}5, D) anti-integrin ß1, E) anti-FN. The control shows an outgrowing cytotrophoblast sheet that varied in thickness from 1–2 cells in proximal areas to about 5 cells near the distal edge. Penetration of the gel by cells is minimal. Cultures treated with antibodies to integrin {alpha}5ß1 (B, C) or FN (E) all contained cytotrophoblastic outgrowths, but these are disrupted. In each case they vary in thickness with a disorganized appearance. In addition, though the majority of extravillous cytotrophoblasts remain at the gel surface, there is a notably increased infiltration of the gel. Antibody to integrin ß1 (D) had similar effects, but in addition an annulus of condensed cytotrophoblast is apparent at the distal edge, with correspondingly fewer cells present in the middle of the outgrowth. Scale bar: 85 µm.



View larger version (92K):
[in this window]
[in a new window]
 
FIG. 4. Transmission electron micrographs of cytotrophoblast outgrowths. A) Cell demonstrating an elongated migratory phenotype at the furthermost tip of the outgrowth. At this point the sheet of cytotrophoblast was one cell thick. The highly indented nucleus is characteristic of post-mitotic cells. The cells contain glycogen masses (*) and scattered microvilli on the apical surface. B) Here the sheet is multilayered. These glycogen-rich cells are at the interface between the ventral surface of the outgrowth and the collagen gel, showing superficial penetration, so that cells near the bottom of the field are embedded within the gel. C) Desmosomes (arrow) and associated intermediate filament bundles (IF) are prominent in some cells in the outgrowths. Scale bar: A) 2.0 µm; B) 3.0 µm; C) 0.25 µm.



View larger version (123K):
[in this window]
[in a new window]
 
FIG. 8. Effects of antibodies to integrin {alpha}5, integrin ß1, and FN on column morphogenesis in vitro. Whole mounts shown at low (left column) and high (right column) magnification after 3 days in culture, the last two in the presence of antibody. The control experiment (A, B) shows extensive sheet outgrowth, with a slight but perceptible thickening at the distal edge (* in A; also visible in B). Here elongated cells are present, with a few scattered rounded single cells. In the presence of function-blocking antibody to integrin {alpha}5 (C, D), column characteristics are altered, with spaces between cells, generating a lacy appearance. The scattered peripheral cell population is reduced. In the presence of anti-integrin ß1 antibody (E, F), an annulus appeared in which cells from the column condense at the periphery of the outgrowth. This is apparent in E, while in F, cell condensation is occurring before the appearance of an annulus. Elongated cells and holes are apparent in the cell sheet between the annulus and the tissue (E). Peripheral single cells are reduced in abundance relative to controls. In the presence of antibody to FN (G, H), the extent of column outgrowth is reduced, but the population of scattered cells is substantially increased. Scale bar: A, C, E, G) 55 µm; B, D, F, H) 150 µm.

The tissue interactions observed with the three gel matrices used for the establishment of first-trimester (8–12 wk) villous explants were quite distinct (Table 2). Attachment of tissue to agarose was poor. No morphological alterations were evident; the villous surfaces remained smooth throughout the experiment (up to 72 h), and there was no evidence from microscopic examination of either whole mounts or semithin sections that any new extravillous trophoblast was being produced. It was concluded that agarose did not support cytotrophoblast outgrowth, and these cultures were not studied further. With Matrigel, attachment was as rapid and efficient as on collagen I (Table 2). Examination of whole mounts at 24 h revealed only subtle changes at the gel-villus tip interface, such as the appearance of rounded surface projections of individual cytotrophoblast cells (Fig. 3B). Cross sections through contact areas showed that cytotrophoblast columns had formed at attachment sites, and invasive fronts of cells proceeded to advance from the surface deeper into the gel bed. The downward direction of migration accounted for the difficulty of observing this phenomenon in whole mounts. In cryosections, several cell columns (often merging) could be seen to develop below the tissue where groups of cells migrated into the gel (Fig. 3D). There was little or no single-cell infiltration of the gel. The cells in the columns were large, rounded, and cytokeratin-positive (Fig. 3D).

Cell Proliferation

Cytotrophoblast proliferation in cultures on matrices of agarose, Matrigel, and collagen I was studied by metabolic labeling with BrdU (Fig. 5). The results showed focal proliferation of cytotrophoblast of proximal columns in culture. Cells of the first few layers of the proximal column were BrdU-positive. In addition, staining was observed in a few villous cytotrophoblast cells at sites not involved in column formation, an observation that supports the continuing viability of the subsyncytial cytotrophoblast population in vitro. On agarose, there were no columns formed in culture, but stem cytotrophoblast cells also incorporated BrdU (not shown).



View larger version (116K):
[in this window]
[in a new window]
 
FIG. 5. Identification of proliferating cells by incorporation of BrdU (100 mM for 48 h) in villi cultured on A) Matrigel and B) collagen I. The direction of cell outgrowth from the villous basement membrane into the forming columns is indicated by arrows. Note that the most proximal cells of the columns forming on collagen I and Matrigel have incorporated the label as well as some of the villous stem cytotrophoblast cells (arrowheads in A). vs, Villous stroma. Scale bar: 50 µm.

The pattern of cell proliferation was also studied by immunolocalization of PCNA (not shown). Anti-PCNA stained predominantly cytotrophoblast cells of the proximal column, but staining was also found more distally among the differentiating cytotrophoblast. Thus considerably more cells stained for PCNA than labeled with BrdU.

In cultures on collagen I, BrdU incorporation was studied as a function of time (Fig. 6). Particular attention was paid to cytotrophoblast of the proximal column, which is the main source of invasive extravillous trophoblast both in vivo and in vitro. BrdU was added to cultures for 5 h on Day 1 (1–6 h and 19–24 h) (Fig. 6). The results showed that cytotrophoblast of the proximal column maintained its proliferative potential for the first 24 h. When BrdU was added on Day 2 (43–48 h), little labeling was observed, indicating that cell proliferation ceased by 48 h of culture (not shown). Dependency of proliferation on factors present in FCS was evaluated by comparison with cultures maintained in serum-free conditions. BrdU incorporation was similar in the two experiments (not shown), suggesting that the presence of serum is not of critical importance for the proliferative burst.



View larger version (72K):
[in this window]
[in a new window]
 
FIG. 6. Proliferative potential of placental villi cultured on collagen I determined by incorporation of BrdU at different times in culture. Sections are shown in brightfield (A, C) or segmented to reveal the immunostaining (B, D). Tissue was cultured for 48 h; BrdU (100 mM) was added from 1 to 5 h (A, B), or 19–24 h (C, D). After the earlier pulse, immunoreactive cells were seen distributed throughout the column (A, B). At the time of the later pulse, incorporation was still occurring in cytotrophoblast cells adjacent to the villous basement membrane, but less movement of labeled cells had occurred into more distal regions of the column. VS, villous stroma. Arrows indicate direction of outgrowth of cell column. Scale bar: 50 µm.

Integrin and FN Expression by Cytotrophoblast

The above results indicated that cell-ECM interactions were critical in the stimulation of de novo column development in vitro. Cultures on gels of collagen I were selected for further studies of the role of integrins at the cell surface and ECM components in these events. Initially it was necessary to establish the patterns of expression of relevant receptors.

Cytotrophoblasts in the developing columns expressed integrins {alpha}1, {alpha}5, and ß1 uniformly after 5-day culture (Fig. 7, A, D, and E). At earlier time points, {alpha}1 was seen at more distal locations in the outgrowth, while {alpha}5 and ß1 were always uniformly positive. The distribution of these two subunits was pericellular within the columns and also strong at the cell-collagen interface. Integrin {alpha}2 was observed in cells in the column, but there was considerable variation in the level of expression (Fig. 7B). More proximal cells in the column sometimes appeared more strongly positive, and no particular accumulation of reactivity was apparent at the cell-collagen interface. Integrin {alpha}4 was weak or absent (Fig. 7C). Integrin {alpha}6 and ß4 subunits were present in regions of cytotrophoblast close to the villous tissue but were lost in more distal areas of outgrowths. Several antibodies were applied that recognize integrins of the {alpha}v family: either {alpha}v itself, the {alpha}vß3 complex, or subunits ß3 or ß5. Staining in the developing outgrowths was weak or negative. These data are summarized in Table 3.



View larger version (94K):
[in this window]
[in a new window]
 
FIG. 7. Integrin expression and oFN production by extravillous cytotrophoblasts migrating over a collagen I gel. Immunofluorescence of trophoblast at the distal tip of outgrowths, stained for A) integrin {alpha}1, B) integrin {alpha}2, C) integrin {alpha}4, D) integrin {alpha}5, E) integrin ß1, F) oFN. Columns extend from left to right in each case across the gel surface, with the collagen gel at the bottom of each field. Integrin subunits {alpha}1, {alpha}5, and ß1 were uniformly positive in the cytotrophoblast population. Integrin {alpha}2 was expressed heterogeneously. Integrin {alpha}4 staining was very weak. oFN was deposited between cytotrophoblasts in the column and on the surface of the gel. Scale bar: 70 µm.


View this table:
[in this window]
[in a new window]
 
TABLE 3. Immunolocalization of integrins, FN, and cytokeratin in explant cultures.a

Localization studies with a polyclonal anti-FN antibody showed widespread staining within the column outgrowth and both at the surface and within the subjacent collagen gel (not shown). To evaluate the contribution of trophoblast-derived fibronectin (oFN) to this matrix, immunolocalization was carried out with mAb X18A4 (Fig. 7F). This showed evidence for production in the outgrowing cells with intracellular staining, accumulation as streaks between cells, and increased staining at the surface of the collagen gel. Staining was also carried out with anti-laminin antibodies (not shown). Columns contained immunoreactive laminin in streaks and spots. However, there was no specific accumulation of laminin at the gel surface beneath outgrowths (not shown).

Integrin and FN Function

The results suggested that the FN-integrin {alpha}5ß1 interaction may be important as a mediator of cytotrophoblast adhesion and/or outgrowth. The involvement of FN, {alpha}5, and ß1 was evaluated using function-perturbing antibodies. Explants were first established for 24 h to allow initial anchorage to the collagen gel and the appearance of foci of trophoblast outgrowth, then exposed to antibody for further periods of up to 5 days. Data are illustrated in Figures 8 and 9 and summarized in Table 4. Control experiments showed development of sheet outgrowths with a uniform appearance in both whole mounts (Fig. 8A) and semithin sections (Fig. 9A). The outgrowths were 1–5 cells thick, with an increase in thickness towards the distal edge (Figs. 8B and 9A). Minimal penetration or infiltration of the gel occurred. Antibodies to integrin {alpha}5 (Fig. 8C, 8D, 9C) and integrin {alpha}5ß1 (Fig. 9B) disrupted the outgrowths, giving rise to rounding of the cells within the columns. This produced a "lacy" appearance in which gaps appeared in the cell sheet. These antibodies also reduced the incidence of elongated or detached cells at the periphery. Morphological changes were also evident in the presence of function-blocking anti-ß1 in the culture medium (Fig. 8E, 8F, 9D). Fewer elongated cells were apparent at the leading edge of the outgrowth. Condensation of cells (as seen in Fig. 8F) often began to be visible at the edges of outgrowths 1 or 2 days after the first exposure to antibody, and this could progress to the formation of a discrete annulus of cells at the periphery of the culture (Figs. 8E and 9D). Between the annulus and the villous tissue, cells aggregated into elongated radial cords (Fig. 8E). Some loss of thickness of the collagen gel was apparent in these areas, as suggested by the need to adjust the focus of the microscope downwards to visualize the network of cells present between the tissue and annulus. When the antibody was added at 48 h, after more column development was evident in the cultures, further spreading of cytotrophoblast across the gel surface was blocked (not shown).


View this table:
[in this window]
[in a new window]
 
TABLE 4. Characteristics of explant cultures after treatment with function-inhibiting antibodies.

As with antibodies to integrin {alpha}5ß1, antibody to FN caused disruption to the structure of the outgrowths without completely inhibiting their formation (Fig. 8G, 8H, 9E). Cell rounding occurred within the outgrowing cytotrophoblast sheets. A few infiltrating cells were apparent within the collagen gel matrix (Fig. 9E). In addition, a substantially larger population of scattered, rounded cells became evident at the periphery of the explant (Fig. 8G and 8H).

Since antibodies to the ß1 integrins did not produce a complete inhibition of outgrowth, there was a need to examine the possibility that other integrins may be important. Integrins of the {alpha}v family act as alternative receptors for FN. Addition of function-blocking antibodies to either {alpha}v or the {alpha}vß3 complex, in the presence or absence of antibodies to integrin ß1, had no consistently inhibitory effect on column outgrowth.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The results suggest that contact with an adhesive substrate stimulates villous cytotrophoblast to proliferate and differentiate, forming outgrowths that anchor the villus to the ECM with continued migration of cells upon or within the substrate for several days. The morphology of these outgrowths, and the cell surface phenotype of the cytotrophoblasts therein, are reminiscent of first-trimester anchoring columns in vivo. In previous investigations, we showed de novo column formation in placental-decidual cocultures at sites of heterotypic contact [10, 11]. This observation raised the question of whether column development requires paracrine signals from decidua or, more simply, contact with an adhesive solid phase. The current experiments demonstrate unequivocally that contact between the tips of first-trimester mesenchymal villi and a permissive ECM (collagen I or Matrigel) is sufficient to stimulate column formation. The localized proliferation of stem cytotrophoblast is indicated by incorporation of BrdU into DNA in proximal column cells and the display of PCNA antigen. Differentiation into the extravillous lineage is indicated by cell surface features including up-regulation of integrin {alpha}5ß1 and {alpha}1ß1 and loss of {alpha}6ß4.

The development of new anchorage sites is specific to the tips of mesenchymal villi in culture; it is not observed in other regions of the villous tree, either at lateral sites in mesenchymal villi or in intermediate villi. This suggests the novel hypothesis that different parts of the villous tree have different developmental potential. Variations might be intrinsic to the cytotrophoblast or might arise as a result of paracrine signalling. Variations in signals reaching the cytotrophoblasts could arise as a result of differences in either the underlying mesenchyme or overlying syncytium in different locations in the villus.

The morphology of cells in the newly formed columns, with abundant intermediate filaments and cytoplasmic glycogen masses, is consistent with features seen in vivo [1]. However, further differentiation in vivo leads to a massive infiltration of single cytotrophoblasts and the formation of giant cells in the placental bed [2]. Neither of these latter phenomena was observed in explant culture; cytotrophoblasts showed cell surface characteristics expected of cells in distal anchoring columns but did not differentiate further to acquire the surface phenotype that has been reported in cells migrating in vivo within maternal blood vessels, such as expression of integrin {alpha}4ß1 or {alpha}vß3 [26]. These findings indicate that cell-matrix interaction at the tip of the mesenchymal villus is sufficient to trigger the first steps of entry into the extravillous lineage but not to produce the further changes characteristic of the endovascular cytotrophoblast population. It is therefore likely that paracrine interactions with maternal or fetal stromal, vascular, or blood-borne substances are required to complete this transition [27]. Numerous factors have been shown to increase the migratory activity of cultured first-trimester cytotrophoblasts (reviewed in [12]). Others have an opposite effect: thus transforming growth factor ß increases production of oFN [28] and increases surface expression of integrins {alpha}1, {alpha}5, and {alpha}v with a concomitant decrease in migratory activity [29]. Blocking the function of its receptor endoglin stimulates outgrowth from villous explant cultures on Matrigel [30]. Activin-A stimulates cytotrophoblast outgrowth from explants, and this is reversible by follistatin [31]. Under conditions of low oxygen tension, cytotrophoblasts remain for longer in the proliferative pool, and the up-regulation of integrin {alpha}1 is inhibited [32].

When tissue was explanted into agarose, viability was maintained, as indicated by the incorporation of BrdU into stem cytotrophoblasts beneath the villous syncytium, but no new extravillous trophoblast was observed to develop, and there was no evidence of adhesion and migration into the surrounding gel. In contrast, anchoring sites developed on collagen I and Matrigel. This indicates that simple physical contact is not sufficient to stimulate column formation and suggests the likelihood of a signalling process that involves interaction between a physiological ECM and cognate receptors on the villus. Since the responses to collagen I and Matrigel differ—the former promoting migration across the surface and the latter stimulating invasion by the cell column—it appears that the respective signalling pathways are distinct. The details of these early recognition and signalling events remain to be defined.

The results indicate that villous tissue from the peripheral regions of the developing placenta retains the potential to generate new anchoring sites at least until the end of the first trimester. Thus as the placenta grows and ramifies, it may continue to develop new anchorage sites, reinforcing attachment to the uterine wall. Examination of the morphology of the developing placenta indicates that indeed anchoring sites increase rapidly in number as the placenta grows during the first trimester [33].

Integrins of the ß1 family including {alpha}1ß1 and {alpha}5ß1 are up-regulated, as seen in columns in vivo [20]. We have also observed {alpha}2ß1, which was not reported in previous studies [20, 21]. In principle, either {alpha}1ß1 or {alpha}2ß1 could act as a receptor for collagen I, mediating cytotrophoblast adhesion and migration over the gel [34, 35]. Integrin {alpha}1ß1 was initially restricted to distal edges of the cytotrophoblast sheet in culture but was later strongly expressed throughout outgrowths. However, {alpha}2ß1 did not appear uniformly on cells in the columns and was often not present in cells at the gel interface. In contrast, {alpha}5 and ß1 were always clearly concentrated at this location, as was FN, which is abundant at corresponding sites in vivo [16]. At least some of this FN was of trophoblastic origin as indicated by the presence of the oncofetal glycopeptide epitope [14, 23]. This suggests that FN acts as a bridging ligand between the collagen matrix and integrin {alpha}5ß1 at the cytotrophoblast surface, mediating anchorage and/or migratory activity. Other FN receptors, including those of the integrin {alpha}v subfamily and {alpha}4ß1 were examined, but levels were very low and current evidence suggests that {alpha}5ß1 is the major FN receptor in this system.

Function-blocking antibodies to {alpha}5, ß1, and the {alpha}5ß1 complex all disrupted the nascent columns, causing alterations in cell patterning within the outgrowing sheet. These alterations are consistent with inhibitory effects on cell-matrix interaction. In addition, a modest increase in penetration of the gel by cells was observed. Anti-FN antibody also disrupted outgrowth architecture, though to a lesser extent than the anti-integrin antibodies, and, in addition, triggered the appearance of a significant population of rounded single cells near the periphery of the outgrowth. These are assumed to have detached from the distal edge of the outgrowth. They remained viable for at least 7 days but migrated no further. These observations are consistent with a role for cell-FN interaction in anchorage site integrity [36, 37].

Although the anti-integrin ß1 antibody used in this study inhibits all members of this integrin subfamily, cell-FN and cell-collagen interactions can also be mediated by {alpha}v integrins, which have been reported on trophoblast [26, 29]. However, expression was low in the explant model, and when the respective function-blocking reagents were included along with anti-ß1, no additional inhibitory effect was observed on the outgrowth. It is important to note that experiments carried out using function-blocking antibodies did not probe tissue-gel attachment, but rather cytotrophoblast outgrowth, which requires prior attachment. Thus the experiment required that initial adhesion occurred before the reagent could be applied. After antibodies were added that disrupted FN-receptor interaction, outgrowth was reduced but not completely blocked. One possible explanation is that currently unrecognized receptor-ligand interactions were operating that do not involve the integrin ß1 subfamily. Another possibility is that antibody access to cell surface locations was incomplete.

The explant model of placental anchoring site development in vitro has revealed a novel aspect of placental function: the capacity to form new peripheral anchoring sites from floating mesenchymal villi that contact the decidual surface. Defects in this process might have important ramifications in pregnancy pathologies such as spontaneous abortion and pre-eclampsia. This model therefore represents a powerful tool for the investigation of a novel aspect of placental function. We have shown that early events in anchoring site morphogenesis are dependent on signals from the ECM and that cell-FN interactions are important in anchorage. We have also shown that these events are sensitive to perturbations in either ECM composition or integrin activity.


    ACKNOWLEDGMENTS
 
We thank Ron Feinberg for antibody to oncofetal fibronectin; Mike Geisow for anti-plasma fibronectin; Martin Humphries, Ken Yamada, and Paul Mould for anti-integrin ß1; Charles Streuli for anti-{alpha}v; Arnoud Sonnenberg for anti-{alpha}6; and Caroline Damsky for anti-{alpha}5.


    FOOTNOTES
 
1 This work was supported by WellBeing (T.H. and H.J.C.), Schering (L.V.), and MRC (H.J.C.). Back

2 Correspondence: John D. Aplin, Research Floor, St. Mary's Hospital, Manchester M13 0JH, UK. FAX: 0161 276 6134; japln{at}mh1.mcc.ac.uk Back

3 Current address: Ljiljana Vi;aacovac, INEP, University of Belgrade, Zemun, Yugoslavia. Back

Accepted: November 5, 1998.

Received: June 29, 1998.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Enders AC. Fine structure of anchoring villi of the human placenta. Am J Anat 1968; 122:419–452.[CrossRef][Medline]
  2. Pijnenborg R, Dixon G, Robertson WB, Brosens I. Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy. Placenta 1980; 1:3–19.[Medline]
  3. Pijnenborg R. Trophoblast invasion. Reprod Med Rev 1994; 3:53–73.
  4. Robertson WB, Brosens I, Landells WN. Abnormal placentation. In: Wynn RM (ed.), Obstetrics and Gynecology Annual, vol. 14. Norwalk, CT: Appleton-Century Crofts; 1985: 411–426.
  5. Librach CL, Werb Z, Fitzgerald ML, Chiu K, Corwin NM, Esteves RA, Grobelny D, Galardy R, Damsky CH, Fisher SJ. 92 kDa type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol 1991; 113:437–449.[Abstract/Free Full Text]
  6. Irving JA, Lysiak JJ, Hearn S, Lala PK. Characterisation of trophoblast cells migrating from first trimester chorionic villous explants and propagated in culture. Placenta 1995; 16:413–433.[CrossRef][Medline]
  7. Cervar M, Puerstner P, Kainer F, Desoye G. Endothelin-1 stimulates the proliferation and invasion of first trimester trophoblastic cells in vitro—a possible role in the etiology of pre-eclampsia? J Invest Med 1996; 44:447–453.
  8. Morrish DW, Dakour J, Li H, Xiao J, Miller R, Sherburne R, Berdan RC, Guilbert LJ. In vitro cultured human term cytotrophoblast: a model for normal primary epithelial cells demonstrating a spontaneous differentiation programme that requires EGF for extensive development of syncytium. Placenta 1997; 18:577–585.[Medline]
  9. Genbacev O, Schubach SA, Miller RK. Villous culture of first trimester human placenta—model to study extravillous trophoblast differentiation. Placenta 1992; 13:439–461.[Medline]
  10. Vi;aacovac Lj, Papic N, Aplin JD. Tissue interactions in first trimester trophoblast-decidua cocultures. Trophoblast Res 1993; 7:223–236.
  11. Vi;aacovac Lj, Jones CJP, Aplin JD. Trophoblast differentiation during formation of anchoring villi in a model of the early human placenta in vitro. Placenta 1995; 16:41–56.[CrossRef][Medline]
  12. Vi;aacovac Lj, Aplin JD. Epithelial-mesenchymal transition during trophoblast differentiation. Acta Anat 1996; 156:202–216.[Medline]
  13. Giancotti FG. Integrin signalling: specificity and control of cell survival and cell cycle progression. Curr Opin Cell Biol 1997; 9:691–700.[CrossRef][Medline]
  14. Feinberg RF, Kliman HJ, Lockwood CJ. Is oncofetal fibronectin a trophoblast glue for human implantation? Am J Pathol 1991; 138:537–543.[Abstract]
  15. Matsuura H, Greene T, Hakomori S. An {alpha}-N-acetyl galactosaminylation at the threonine residue of a defined peptide sequence creates the oncofetal peptide epitope in human fibronectin. J Biol Chem 1989; 264:10472–10476.[Abstract/Free Full Text]
  16. Aplin JD, Charlton AK. The role of matrix macromolecules in the invasion of decidua by trophoblast. Trophoblast Res 1990; 4:139–158.
  17. Aplin JD. Implantation, trophoblast differentiation and haemochorial placentation: mechanistic evidence in vivo and in vitro. J Cell Sci 1991; 99:681–692.[Medline]
  18. Aplin JD. Expression of integrin {alpha}6ß4 in human trophoblast and its loss from extravillous cells. Placenta 1993; 14:203–215.[CrossRef][Medline]
  19. Aplin JD. The cell biology of human implantation. Placenta 1996; 17:269–276.[CrossRef][Medline]
  20. Damsky CH, Fitzgerald ML, Fisher SJ. Distribution of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo. J Clin Invest 1992; 89:210–222.
  21. Korhonen M, Ylanne J, Laitinen L, Cooper HM, Quaranta V, Virtanen I. Distribution of the {alpha}1-{alpha}6 integrin subunits in human developing and term placenta. Lab Invest 1991; 65:347–356.[Medline]
  22. Aplin JD, Sattar A, Mould AP. Variant choriocarcinoma (BeWo) cells with differing adhesion and migration to fibronectin display conserved patterns of integrin expression. J Cell Sci 1992; 103:435–444.[Abstract]
  23. Feinberg RF, Kliman HJ, Bedian V, Monzon-Bordonaba F, Menzin AW, Wang C-L. Monoclonal antibody X18A4 identifies an oncofetal fibronectin epitope distinct from the FDC-6 binding site. Am J Obstet Gynecol 1995; 172:1526–1536.[CrossRef][Medline]
  24. Akiyama SK, Yamada SS, Chen WT, Yamada KM. Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization. J Cell Biol 1989; 109:863–875.[Abstract/Free Full Text]
  25. Mould AP, Akiyama SK, Humphries MJ. The inhibitory anti-ß1 integrin monoclonal antibody 13 recognizes an epitope that is attenuated by ligand occupancy: evidence for allosteric inhibition of integrin function. J Biol Chem 1996; 271:20365–20374.[Abstract/Free Full Text]
  26. Zhou Y, Fisher SJ, Janatpour M, Genbacev O, Dejana E, Wheelock M, Damsky CH. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. J Clin Invest 1997; 99:2139–2151.[Medline]
  27. Aplin JD, Glasser SR. The interaction of trophoblast with endometrial stroma. In: Glasser SR (ed.), Endocrinology of Embryo-Endometrium Interactions. New York: Plenum Press; 1994: 327–341.
  28. Feinberg RF, Kliman HJ, Wang C-L. Transforming growth factor stimulates trophoblast oncofetal fibronectin synthesis in vitro: implications for trophoblast implantation in vivo. J Clin Endocrinol Metab 1994; 78:1241–1248.[Abstract]
  29. Irving JA, Lala PK. Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGFß, IGF-II and IGFBP-1. Exp Cell Res 1995; 217:419–427.[CrossRef][Medline]
  30. Caniggia I, Taylor CV, Knox Ritchie JW, Lye SJ, Letarte M. Endoglin regulates trophoblast differentiation along the invasive pathway in human placental villous explants. Endocrinology 1997; 138:4977–4988.[Abstract/Free Full Text]
  31. Caniggia I, Lye SJ, Cross J. Activin is a local regulator of human cytotrophoblast cell differentiation. Endocrinology 1997; 138:3976–3986.[Abstract/Free Full Text]
  32. Genbacev O, Zhou Y, Ludlow JW, Fisher SJ. Regulation of human placental development by oxygen tension. Science 1997; 277:1669–1672.[Abstract/Free Full Text]
  33. Boyd JD, Hamilton WJ. The Human Placenta. London: The Macmillan Press; 1970.
  34. Ruggiero F, Comte J, Cabanas C, Garrone R. Structural requirements for {alpha}1ß1 and {alpha}2ß1 integrin-mediated cell adhesion to collagen V. J Cell Sci 1996; 109:1865–1874.[Abstract]
  35. Messent AJ, Tuckwell DS, Knäuper V, Humphries MJ, Murphy G, Gavrilovic J. Effects of collagenase cleavage of type I collagen on {alpha}2ß1 integrin-mediated cell adhesion. J Cell Sci 1998; 111:1127–1135.[Abstract]
  36. Aplin JD, Charlton AK, Ayad S. An immunohistochemical study of human endometrial extracellular matrix during the menstrual cycle and first trimester of pregnancy. Cell Tissue Res 1988; 253:231–240.[Medline]
  37. Damsky CH, Librach C, Lim K-H, Fitzgerald ML, McMaster MT, Janatpour M, Zhou Y, Logan SK, Fisher SJ. Integrin switching regulates normal trophoblast invasion. Development 1994; 120:3657–3666.[Abstract]



This article has been cited by other articles:


Home page
EndocrinologyHome page
E. Yamamoto, K. Ino, E. Miyoshi, K.-i. Inamori, A. Abe, S. Sumigama, A. Iwase, H. Kajiyama, K. Shibata, A. Nawa, et al.
N-Acetylglucosaminyltransferase V Regulates Extravillous Trophoblast Invasion through Glycosylation of {alpha}5{beta}1 Integrin
Endocrinology, February 1, 2009; 150(2): 990 - 999.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. Fafet, C. Rebouissou, T. Maudelonde, and M.-L. Vignais
Opposite Effects of Transforming Growth Factor-{beta} Activation and Rho-Associated Kinase Inhibition on Human Trophoblast Migration in a Reconstituted Placental-Endometrial Coculture System
Endocrinology, September 1, 2008; 149(9): 4475 - 4485.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
Y. Hu, R. Tan, C. D. MacCalman, G. Eastabrook, S.-H. Park, J. P. Dutz, and P. von Dadelszen
IFN-{gamma}-mediated extravillous trophoblast outgrowth inhibition in first trimester explant culture: a role for insulin-like growth factors
Mol. Hum. Reprod., May 1, 2008; 14(5): 281 - 289.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S.K.M. Seeho, J.H. Park, J. Rowe, J.M. Morris, and E.D.M. Gallery
Villous explant culture using early gestation tissue from ongoing pregnancies with known normal outcomes: the effect of oxygen on trophoblast outgrowth and migration
Hum. Reprod., May 1, 2008; 23(5): 1170 - 1179.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Nicola, A. Chirpac, P. K. Lala, and C. Chakraborty
Roles of Rho Guanosine 5'-Triphosphatase A, Rho Kinases, and Extracellular Signal Regulated Kinase (1/2) in Prostaglandin E2-Mediated Migration of First-Trimester Human Extravillous Trophoblast
Endocrinology, March 1, 2008; 149(3): 1243 - 1251.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K. Y Arai and T. Nishiyama
Developmental Changes in Extracellular Matrix Messenger RNAs in the Mouse Placenta During the Second Half of Pregnancy: Possible Factors Involved in the Regulation of Placental Extracellular Matrix Expression
Biol Reprod, December 1, 2007; 77(6): 923 - 933.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
R. Ganapathy, G. S. J. Whitley, J.E. Cartwright, P.R. Dash, and B. Thilaganathan
Effect of heparin and fractionated heparin on trophoblast invasion
Hum. Reprod., September 1, 2007; 22(9): 2523 - 2527.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
G. St. J. Whitley, P. R. Dash, L.-J. Ayling, F. Prefumo, B. Thilaganathan, and J. E. Cartwright
Increased Apoptosis in First Trimester Extravillous Trophoblasts from Pregnancies at Higher Risk of Developing Preeclampsia
Am. J. Pathol., June 1, 2007; 170(6): 1903 - 1909.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. Tartakover-Matalon, N. Cherepnin, M. Kuchuk, L. Drucker, I. Kenis, A. Fishman, M. Pomeranz, and M. Lishner
Impaired migration of trophoblast cells caused by simvastatin is associated with decreased membrane IGF-I receptor, MMP2 activity and HSP27 expression
Hum. Reprod., April 1, 2007; 22(4): 1161 - 1167.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Hu, J. P. Dutz, C. D. MacCalman, P. Yong, R. Tan, and P. von Dadelszen
Decidual NK Cells Alter In Vitro First Trimester Extravillous Cytotrophoblast Migration: A Role for IFN-{gamma}
J. Immunol., December 15, 2006; 177(12): 8522 - 8530.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Rahnama, F. Shafiei, P. D. Gluckman, M. D. Mitchell, and P. E. Lobie
Epigenetic Regulation of Human Trophoblastic Cell Migration and Invasion
Endocrinology, November 1, 2006; 147(11): 5275 - 5283.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. L. James, P.R. Stone, and L.W. Chamley
The effects of oxygen concentration and gestational age on extravillous trophoblast outgrowth in a human first trimester villous explant model
Hum. Reprod., October 1, 2006; 21(10): 2699 - 2705.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
L.J. Ayling, G.St.J. Whitley, J.D. Aplin, and J.E. Cartwright
Dimethylarginine dimethylaminohydrolase (DDAH) regulates trophoblast invasion and motility through effects on nitric oxide
Hum. Reprod., October 1, 2006; 21(10): 2530 - 2537.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
P.A. Elustondo, G.E. Hannigan, I. Caniggia, and D.J. MacPhee
Integrin-Linked Kinase (ILK) Is Highly Expressed in First Trimester Human Chorionic Villi and Regulates Migration of a Human Cytotrophoblast-Derived Cell Line
Biol Reprod, May 1, 2006; 74(5): 959 - 968.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
J. L James, P. R Stone, and L. W Chamley
Cytotrophoblast differentiation in the first trimester of pregnancy: evidence for separate progenitors of extravillous trophoblasts and syncytiotrophoblast
Reproduction, July 1, 2005; 130(1): 95 - 103.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
F. Mondon, T.-M. Mignot, R. Rebourcet, H. Jammes, J.-L. Danan, F. Ferre, and D. Vaiman
Profiling of oxygen-modulated gene expression in early human placenta by systematic sequencing of suppressive subtractive hybridization products
Physiol Genomics, June 16, 2005; 22(1): 99 - 107.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. B. Laoag-Fernandez, H. Matsuo, H. Murakoshi, A. L. Hamada, B. K. Tsang, and T. Maruo
3,5,3'-Triiodothyronine Down-Regulates Fas and Fas Ligand Expression and Suppresses Caspase-3 and Poly (Adenosine 5'-Diphosphate-Ribose) Polymerase Cleavage and Apoptosis in Early Placental Extravillous Trophoblasts in Vitro
J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 4069 - 4077.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
H. A. Coppock, A. White, J. D. Aplin, and M. Westwood
Matrix Metalloprotease-3 and -9 Proteolyze Insulin-Like Growth Factor-Binding Protein-1
Biol Reprod, August 1, 2004; 71(2): 438 - 443.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M.-J. Lee, Y. Ma, L. LaChapelle, S. S. Kadner, and S. Guller
Glucocorticoid Enhances Transforming Growth Factor-{beta} Effects on Extracellular Matrix Protein Expression in Human Placental Mesenchymal Cells
Biol Reprod, May 1, 2004; 70(5): 1246 - 1252.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Bauer, J. Pollheimer, J. Hartmann, P. Husslein, J. D. Aplin, and M. Knofler
Tumor Necrosis Factor-{alpha} Inhibits Trophoblast Migration through Elevation of Plasminogen Activator Inhibitor-1 in First-Trimester Villous Explant Cultures
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 812 - 822.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
Y. Nishioka, T. Higuchi, Y. Sato, S. Yoshioka, K. Tatsumi, H. Fujiwara, and S. Fujii
Human migrating extravillous trophoblasts express a cell surface peptidase, carboxypeptidase-M
Mol. Hum. Reprod., December 1, 2003; 9(12): 799 - 806.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. Pavan, A. Tarrade, A. Hermouet, C. Delouis, M. Titeux, M. Vidaud, P. Therond, D. Evain-Brion, and T. Fournier
Human invasive trophoblasts transformed with simian virus 40 provide a new tool to study the role of PPAR{gamma} in cell invasion process
Carcinogenesis, August 1, 2003; 24(8): 1325 - 1336.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
L. Qin, Y.-L. Wang, S.-X. Bai, S.-H. Ji, W. Qiu, S. Tang, and Y.-S. Piao
Temporal and Spatial Expression of Integrins and Their Extracellular Matrix Ligands at the Maternal-Fetal Interface in the Rhesus Monkey During Pregnancy
Biol Reprod, August 1, 2003; 69(2): 563 - 571.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
T. Higuchi, H. Fujiwara, H. Egawa, Y. Sato, S. Yoshioka, K. Tatsumi, K. Itoh, M. Maeda, J. Fujita, and S. Fujii
Cyclic AMP enhances the expression of an extravillous trophoblast marker, melanoma cell adhesion molecule, in choriocarcinoma cell JEG3 and human chorionic villous explant cultures
Mol. Hum. Reprod., June 1, 2003; 9(6): 359 - 366.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
V. Jokimaa, S. Oksjoki, H. Kujari, E. Vuorio, and L. Anttila
Altered expression of genes involved in the production and degradation of endometrial extracellular matrix in patients with unexplained infertility and recurrent miscarriages
Mol. Hum. Reprod., December 1, 2002; 8(12): 1111 - 1116.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Sato, H. Fujiwara, T. Higuchi, S. Yoshioka, K. Tatsumi, M. Maeda, and S. Fujii
Involvement of Dipeptidyl Peptidase IV in Extravillous Trophoblast Invasion and Differentiation
J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4287 - 4296.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
G. Xu, M.-J. Guimond, C. Chakraborty, and P. K. Lala
Control of Proliferation, Migration, and Invasiveness of Human Extravillous Trophoblast by Decorin, a Decidual Product
Biol Reprod, August 1, 2002; 67(2): 681 - 689.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M.O. Babawale, M.A. Mobberley, T.A. Ryder, M.G. Elder, and M.H.F. Sullivan
Ultrastructure of the early human feto-maternal interface co-cultured in vitro
Hum. Reprod., May 1, 2002; 17(5): 1351 - 1357.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. Lyall, H. Simpson, J. Nicola Bulmer, A. Barber, and S. Courtenay Robson
Transforming Growth Factor-{beta} Expression in Human Placenta and Placental Bed in Third Trimester Normal Pregnancy, Preeclampsia, and Fetal Growth Restriction
Am. J. Pathol., November 1, 2001; 159(5): 1827 - 1838.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. M. Gleeson, C. Chakraborty, T. McKinnon, and P. K. Lala
Insulin-Like Growth Factor-Binding Protein 1 Stimulates Human Trophoblast Migration by Signaling through {{alpha}}5{beta}1 Integrin via Mitogen-Activated Protein Kinase Pathway
J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2484 - 2493.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
Y. Ma, C. J. Lockwood, A. L. Bunim, D. A. Giussani, P. W. Nathanielsz, and S. Guller
Cell Type-Specific Regulation of Fetal Fibronectin Expression in Amnion: Conservation of Glucocorticoid Responsiveness in Human and Nonhuman Primates
Biol Reprod, June 1, 2000; 62(6): 1812 - 1817.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
B. A. Kilburn, J. Wang, Z. M. Duniec-Dmuchkowski, R. E. Leach, R. Romero, and D. R. Armant
Extracellular Matrix Composition and Hypoxia Regulate the Expression of HLA-G and Integrins in a Human Trophoblast Cell Line
Biol Reprod, March 1, 2000; 62(3): 739 - 747.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aplin, J. D.
Right arrow Articles by Vicovac, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aplin, J. D.
Right arrow Articles by Vicovac, L.
Agricola
Right arrow Articles by Aplin, J. D.
Right arrow Articles by Vicovac, L.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS